[go: up one dir, main page]

WO2012018779A2 - Valvule extensible et son procédé d'utilisation - Google Patents

Valvule extensible et son procédé d'utilisation Download PDF

Info

Publication number
WO2012018779A2
WO2012018779A2 PCT/US2011/046216 US2011046216W WO2012018779A2 WO 2012018779 A2 WO2012018779 A2 WO 2012018779A2 US 2011046216 W US2011046216 W US 2011046216W WO 2012018779 A2 WO2012018779 A2 WO 2012018779A2
Authority
WO
WIPO (PCT)
Prior art keywords
valve
expandable
frame
valve frame
diameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/046216
Other languages
English (en)
Other versions
WO2012018779A3 (fr
Inventor
James Lock
Jesse Lock
Doff Mcelhinney
Pedro J. Del Nido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of WO2012018779A2 publication Critical patent/WO2012018779A2/fr
Publication of WO2012018779A3 publication Critical patent/WO2012018779A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter

Definitions

  • Natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary valves.
  • Aortic and pulmonary valves commonly referred to as semilunar valves, are located at the base of the aorta and the pulmonary artery, respectively.
  • the semilunar valves have three cusps and permit blood to flow into the arteries while preventing backflow of blood from the arteries into the ventricles.
  • the aortic valve lies between the left ventricle and the aorta, and the pulmonary valve lies between the right ventricle and the pulmonary artery.
  • aortic and pulmonary valves Stenosis and regurgitation of aortic and pulmonary valves in the heart can cause chronic ventricular pressure and volume loads leading to short term and long term morbidity, as well as mortality.
  • a therapeutic option for patients that suffer from eventual ventricular failure is aortic or pulmonary valve replacement.
  • pulmonary or aortic valve replacement with a bioprosthesis has been associated with progressive valve deterioration despite significant anticoagulation therapy.
  • Transcatheter valve replacement is a strategy for mitigating problems associated with multiple surgical procedures and/or palliative medical care.
  • Valve implants are designed to replace the trileaflet structure that extends from a valve circumference to a radial center point of the valve, with each leaflet contacting or slightly overlapping the two adjacent leaflets.
  • An expandable valve may include an expandable valve frame disposed about a number of valve leaflets where the diameter of the expandable valve frame may be suitably increased when a sufficient outward force is applied to the frame.
  • valve leaflets disposed within the valve frame may also be stretched along with the frame so that the diameter of the entire valve is increased.
  • the expandable valve frame may be appropriately expanded to accommodate growth in young patients.
  • the diameter of an expandable valve frame may be increased through use of a dilation balloon catheter.
  • an expandable valve conduit includes an expandable valve disposed within a covered stent having expandable cuffs attached at opposing ends of the stent.
  • the expandable valve conduit may be implanted within the body (e.g., by suturing the expandable cuffs to suitable regions of tissue) so as to provide a passageway for fluid (e.g., blood) to flow through the valve and between cavities.
  • the expandable valve conduit may provide for suitable passage of fluid between the right ventricle and the main pulmonary artery.
  • a valve for implantation at a semilunar position of a heart includes valve leaflets; and an expandable rigid valve frame cooperating with and disposed about the valve leaflets to support the leaflets, the rigid valve frame adapted for implantation at the semilunar position of the heart, the rigid valve frame having a ring diameter, the rigid valve frame constructed and arranged to be expanded in ring diameter after implantation from a first functioning valve diameter to a second functioning valve diameter, wherein upon application of an outward force to the rigid valve frame, the ring diameter of the rigid valve frame is increased.
  • a medical device for implantation within a body to form a passageway between a first tissue region and a second tissue region.
  • the device includes a conduit having a first end portion, a second end portion, and a lumen; a valve disposed within the lumen; a first expandable cuff disposed at the first end portion of the conduit, the first expandable cuff constructed and arranged to be sutured to the first tissue region; and a second expandable cuff disposed at the second end portion of the conduit, the second expandable cuff constructed and arranged to be sutured to the second tissue region.
  • a method of correcting artificial heart valve function for a patient having a previously implanted first valve assembly at a semilunar position of the heart, the first valve assembly having valve leaflets attached to a first valve frame, the first valve frame having a diameter.
  • the method includes applying an outward force to the first valve frame to increase the diameter of the first valve frame; and implanting a second valve assembly in a resulting lumen whereby the second valve assembly replaces the function of the first valve assembly, wherein the first valve frame is constructed and arranged as a docking station for the second valve assembly and at least one of the first valve frame and the second valve assembly is expandable.
  • a method of improving heart valve function for a patient includes implanting a valve at a semilunar position of the heart having an abnormally small annulus, the valve having leaflets attached to an expandable valve frame, and the valve frame having a diameter; and applying a radially outward force to the valve frame such that the diameter of the valve frame increases such that the small annulus at the semilunar position of the heart increases.
  • a method of improving heart valve function for a growing patient includes implanting a valve at a semilunar position of the heart having an abnormally small annulus, the valve having leaflets attached to an expandable valve frame, and the valve frame having a diameter; and applying a radially outward force to the valve frame upon patient growth such that the diameter of the valve frame can increase as the patient grows.
  • a method of manufacturing a medical device for implantation within a body to form a conduit between a first tissue region and a second tissue region includes forming a tube having a first end portion, a second end portion, and a lumen; placing an anatomical valve within the lumen of the tube; attaching a first expandable cuff to the first end portion, the first expandable cuff constructed and arranged to be sutured to the first tissue region; and attaching a second expandable cuff to the second end portion, the second expandable cuff constructed and arranged to be sutured to the second tissue region.
  • a method for treating a pulmonary artery includes providing a device having a tube defining a lumen, the device having a valve disposed in the lumen, a first expandable cuff disposed at a first end portion of the tube, and a second expandable cuff disposed at a second end portion of the tube; suturing a portion of the first expandable cuff to a first tissue region; and suturing a portion of the second expandable cuff to a second tissue region, thereby forming a conduit to provide fluid communication between the first tissue region and the second tissue region through the device.
  • FIG. 1A depicts a top view of a conventional valve having a frame
  • FIG. IB depicts a side view of a conventional valve having a frame implanted within a vessel
  • FIG. 2A depicts a side view of a valve having an expandable valve frame implanted within a vessel
  • FIG. 2B depicts a side view of a valve having an expandable valve frame implanted in a vessel, with a catheter and balloon assembly positioned within the valve prior to dilation and expansion of the valve frame;
  • FIG. 2C depicts a side view of the balloon inflated and increasing the diameter of the expandable valve frame arrangement in the vessel of FIG. 2B;
  • FIG. 3A depicts a side view of a vessel with a previously implanted valve having an expandable valve frame in a vessel and a transcatheter valve assembly with a catheter and balloon prior to implantation of the transcatheter valve within the expandable valve frame;
  • FIG. 3B depicts a side view of the catheter, balloon, and valve assembly crossing the expandable valve frame, prior to implantation of the transcatheter valve within the expandable valve frame;
  • FIG. 3C depicts a side view of the balloon from the transcatheter valve implant system inflated, implanting the transcatheter valve and increasing the diameter of the expandable valve frame;
  • FIG. 4 depicts a perspective view of one embodiment of a valve having an expandable valve frame in an unexpanded configuration;
  • FIG. 5 depicts a perspective view of the valve having the expandable valve frame shown in FIG. 4 in a partially expanded configuration
  • FIG. 6A depicts a close side view of a strut that spans segments of an expandable valve frame prior to expansion
  • FIG. 6B depicts a close side view of a strut that spans segments of an expandable valve frame upon expansion
  • FIG. 7 depicts a perspective view of another embodiment of a valve having an expandable valve frame in an expanded configuration
  • FIG. 8A depicts a close side view of a strut that is located at a central region of segments of an expandable valve frame prior to expansion;
  • FIG. 8B depicts a close side view of a strut that is located at a central region of segments of an expandable valve frame upon expansion;
  • FIG. 9 depicts a close perspective view of a one-way ratchet mechanism for an expandable valve frame
  • FIG. 10 depicts a close perspective view of another one-way ratchet mechanism for an expandable valve frame
  • FIG. 11 depicts a close perspective view of a toothed post of a joint for an expandable valve frame
  • FIG. 12 depicts a close perspective view of a ball-in-joint ratchet mechanism with a circular cross-section for an expandable valve frame
  • FIG. 13 depicts a close perspective view of a ball-in-joint ratchet mechanism with a rectangular cross-section for an expandable valve frame
  • FIG. 14 depicts a schematic view of one embodiment of a joint for an expandable valve frame
  • FIG. 15 depicts a close schematic view of an embodiment of a joint for an expandable valve frame
  • FIG. 16 depicts a close schematic view of another embodiment of a joint for an expandable valve frame
  • FIG. 17 depicts a close schematic view of a further embodiment of a joint for an expandable valve frame
  • FIG. 18 depicts a close schematic view of yet another embodiment of a joint for an expandable valve frame
  • FIG. 19A depicts a close schematic view of another embodiment of a joint for an expandable valve frame in an unexpanded configuration
  • FIG. 19A depicts a partial perspective view of a further embodiment of an expandable valve frame with concentric rings in an unexpanded configuration
  • FIG. 19B depicts a partial perspective view of the expandable valve frame shown in
  • FIG. 16A in a partially expanded configuration
  • FIG. 20 depicts another schematic view of one embodiment of an expandable valve frame comprising a plurality of overlapping crescent- shaped arcuate segments
  • FIG. 21 is a perspective representation of another embodiment of a ratcheting arrangement for the expandable valve frame depicting a catch wheel ratcheting arrangement
  • FIGS. 22A-22C depict a series of discrete-diameter expansions of the expandable valve frame
  • FIGS. 23A-23R are schematic plan representations of various features and configurations for the expandable valve frame
  • FIG. 24A depicts the expandable valve frame encased in a protective sheath
  • FIG. 24B is a representation of FIG. 24A with the protective sheath shown in phantom to reveal the expandable valve frame;
  • FIG. 25 is a perspective view of the expandable valve frame shown in phantom, with a valve leaflet attachment frame wrapped around the expandable valve frame;
  • FIG. 26 shows an embodiment of an expandable valve conduit with a valve disposed within a stent and expandable cuffs attached at opposite ends of the stent;
  • FIG. 27 shows an embodiment of a curved mandrel
  • FIG. 28 depicts an embodiment of a restrictor engaged with a portion of a stent
  • FIG. 29 illustrates a schematic of an expandable valve frame in accordance with embodiments described
  • FIGS. 30A-30D are schematic plan representations of various examples of the expandable valve frame in accordance with FIGS. 23 A, 23B, 23E, and 23M;
  • FIGS. 31A-31D are more schematic plan representations of various examples of the expandable valve frame in accordance with FIGS. 23 A, 23B, 23E, and 23M;
  • FIGS. 32A-32D are further schematic plan representations of various examples of the expandable valve frame in accordance with FIGS. 23 A, 23B, 23E, and 23M
  • FIGS. 33A-33C are schematic plan representations of various examples of the expandable valve frame in accordance with FIGS. 23A, 23B, and 23M;
  • FIGS. 34A and 34B are schematic plan representations of various examples of the expandable valve frame in accordance with FIGS. 23 A and 23B;
  • FIG. 35 depicts a graph of load versus valve frame deformation for an example in accordance with embodiments herein.
  • FIG. 36 depicts a graph of load versus valve frame deformation for another example in accordance with embodiments herein.
  • FIGS. 1A and IB depict a prosthetic valve 10 having valve leaflets 20a, 20b, and 20c attached to a valve frame 30 for implantation at a semilunar position of the heart.
  • FIG. IB shows the valve 10 implanted in a vessel 12.
  • the valve frame 30 is attached (not shown) to the surrounding tissue of the vessel 12.
  • a recently developed alternative to surgical replacement of the deteriorated prosthetic valve is implantation of a transcatheter valve within the existing valve. Deterioration of the transcatheter valve may be treated with concentric implantation of an additional transcatheter valve within the first. However, implantation of subsequent transcatheter valves
  • concentrically within a previously implanted transcatheter valve may give rise to intraluminal bulk that decreases effective orifice area. Such decrease in lumen size may cause obstruction of the subsequently placed valve, and is especially counterproductive if the patient grows, or requires a higher cardiac output, after implantation of the valve.
  • an important problem in a subset of patients undergoing replacement of the aortic valve is a small aortic annulus.
  • the valve prosthesis occupies space, and in patients with a relatively small native annulus, insertion of a prosthetic valve may result in residual left ventricular outflow tract obstruction and incomplete relief of symptoms and
  • Methods to overcome the problem of the small aortic annulus include technical surgical modifications of the aortic valve replacement to enlarge the annulus (e.g., by incising through the annulus into the ventricular septum, the anterior leaflet of the mitral valve, or otherwise), implantation of the valve in a supraannular position, or insertion of a low-profile valve.
  • a prosthetic expandable valve is disclosed. Expanding the valve can be used to improve heart function, as will be described.
  • the valve may be implanted surgically at a size that the annulus will accommodate. Afterward, the valve and annulus would be enlarged, (e.g., intraoperatively or later in the catheterization lab). The valve may be enlarged, for example, by inflating a balloon within the valve or by using another method of dilation and expanding the valve. In some cases, the valve may be implanted in a younger patient where further growth of the annulus may occur. To accommodate patient growth, the diameter of the expandable valve frame may be increased to maintain functionality of the implanted valve. In some cases, when a previously implanted valve becomes dysfunctional, an expandable valve may be used as a docking station for implantation of a subsequent valve.
  • a valve prosthesis that includes an expandable valve frame for implantation at a semilunar position of the heart.
  • the expandable valve frame cooperates with and is disposed about valve leaflets.
  • an outward force is applied to the expandable valve frame, the diameter of the frame is increased in a controlled and predictable fashion.
  • a method of using an expandable valve frame for correcting artificial heart valve function in a patient is described.
  • the expandable valve frame is useful for restoring function of a previously implanted valve where the valve was implanted at a semilunar position of the heart.
  • An outward force may also be applied to the frame, reducing obstruction in the original valve and reducing obstruction at the original valve.
  • transcatheter valve assembly may also be implanted in the lumen where the first valve was previously implanted such that the second valve assembly replaces the function of the first valve, for example, supporting the previously implanted valve or replacing the first valve entirely. Because of the expandable frame of the first valve, implantation of the second valve will not cause narrowing of the lumen within the vessel as a result of the combined bulk of the originally implanted and subsequent replacement valves.
  • FIG. 2A illustrates an embodiment of a valve 11 with an expandable valve frame 50 implanted at a semilunar position of a vessel 12.
  • the valve 11 includes an expandable valve frame 50 and valve leaflets 20 and is attached (e.g., sutured) to the surrounding tissue of the vessel 12.
  • the expandable valve frame 50 also includes expansion joints 52 that serve as expandable connections and provide a method for which the diameter of the expandable valve frame 50 may be increased in a controlled and predictable fashion.
  • an appropriate biocompatible material suitable for use in a heart valve may surround the valve frame, but is not shown for the purposes of clarity. In one embodiment, however, the material is stretchable so as to accommodate expanding valve diameters.
  • the expandable valve frame addresses problems that arise at the semilunar heart valve position when the outermost valve or prosthesis is fixed in diameter. For example, as current replacement heart valves and associated suture rings have a rigid and fixed diameter, progressive crowding in the lumen and/or leaflet restriction may occur if multiple valves are implanted subsequently and concentrically at the same location.
  • the circumference and diameter of the expandable valve frame may increase in a predictable and precise manner when sufficient outward force (e.g., from inflation of a high-pressure angioplasty balloon or through a different appropriate surgical procedure) is applied to the valve frame.
  • the expandable valve frame may serve as a docking station in allowing for concentric placement of multiple transcatheter (e.g., stent mounted) valves at the same position over time without substantially incremental narrowing of the lumen.
  • the expandable valve frame may substantially resist compressive, rotational and torsional forces exerted by the beating heart.
  • the expandable valve frame may remain resistant to compressive loads so as to thereby serve as a docking station.
  • the expandable valve frame may be approximately circularly symmetric so as to be implantable in a semilunar valve position of the heart. As a result, multiple valves may be placed concentrically over time at an aorta or pulmonary valve position providing for appropriate unidirectional flow of fluid away from the ventricle without compromising valve functionality.
  • the expandable valve frame may be implanted simultaneously along with or as a part of a valve assembly.
  • the expandable valve frame may be a part of a valve (i.e., attached to the valve) prior to implantation so that the valve is implanted together with the expandable valve frame at an aortic or pulmonary valve position.
  • the valve frame may function as an implant site for future valve replacements (e.g., semilunar valve replacements), allowing for multiple valves to be implanted sequentially over time.
  • the expandable valve frame to be implanted at a semilunar position may include any appropriate material.
  • the expandable valve frame is made up of a rigid material.
  • the frame may be made from metal (e.g., stainless steel, alloys of suitable metals, etc.), shape memory material (e.g., nitinol), polymer (e.g., synthetic and/or naturally occurring), silicon, rubber, tissue (e.g., allograft and/or xenograft), and/or combinations thereof.
  • the frame may be appropriately attached to the surrounding tissue.
  • the frame is sutured to the surrounding tissue at the semilunar position.
  • standard suture materials may be wrapped around the body of the expandable valve frame, allowing the frame and the tissue to be sutured together.
  • the body of the expandable valve frame may include suture holes where suture material may be threaded so that the valve frame and the tissue may be sutured together.
  • the expandable frame may be covered with a material that can be sutured to the surrounding tissue.
  • aspects of the expandable frame promote tissue ingrowth such that the surrounding tissue provides for a biological attachment of the frame at a semilunar position.
  • the expandable frame may include a coating or a copolymer having an appropriate biomolecular arrangement that encourages tissue growth around the expandable frame.
  • portions of the expandable frame may be attached to surrounding tissue at a semilunar position through a variety of other methods, such as through tissue welding (e.g., using laser and/or heat treatment), surgical staples, surgical adhesives (e.g., glue), and/or combinations thereof.
  • tissue welding e.g., using laser and/or heat treatment
  • surgical staples e.g., surgical staples
  • surgical adhesives e.g., glue
  • valve leaflets may be made from polymer (e.g., synthetic and/or naturally occurring), tissue (e.g., allograft and/or xenograft), and/or combinations thereof.
  • tissue e.g., allograft and/or xenograft
  • valve leaflets may be bioprosthetic valve leaflets and/or completely artificial valve leaflets.
  • an appropriate surgical tool may be used to apply outward force to the expandable valve frame.
  • a balloon-mounted stent may be used to position a valve in the expandable valve frame and provide an outward force to the expandable valve frame upon inflation of the balloon.
  • the balloon may be inflated in a controlled manner such that a predictable outward force is applied to the expandable valve frame.
  • a ratchet mechanism may be provided in the expandable valve frame and may be configured such that known and increasing forces are required for increasing the diameter of the expandable valve frame to successively larger diameters.
  • the diameter of the expandable valve frame may be manually increased through appropriate tool manipulation.
  • a valve may be surgically implanted into a small annulus at a diameter that is appropriate for the annulus size, and the valve may be expanded either during the same surgery or later by transcatheter methods to a larger diameter for improving valve function.
  • valve leaflets may be designed to optimize coaptation and load bearing after implant and expansion (e.g., increasing the diameter by 10-20%).
  • FIGS. 2A-2C show an illustrative embodiment of a valve 11 that is implanted at a vessel 12 of a semilunar position of the heart, the valve having valve leaflets 20 and an expandable valve frame 50.
  • FIG. 2A depicts an implanted valve 11, while FIGS 2B and 2C depict enlargement of the valve 11 having an expandable valve frame 50 through use of a balloon 4.
  • the expandable valve frame 50 and the valve leaflets 20 may be attached to one another by any appropriate method. In some
  • an interlocking mechanism serves to attach the expandable valve frame and the valve leaflets to one another.
  • the expandable valve frame 50 and the valve leaflets 20 may include a complementary flanged configuration that allows for the expandable valve frame 50 and the valve leaflets 20 to be appropriately attached.
  • the expandable valve frame 50 and the valve leaflets 20 are sutured together.
  • the expandable valve frame 50 and the valve leaflets 20 are formed as a unitary piece.
  • the expandable valve frame 50 may be surgically implanted at a semilunar position of the heart simultaneously with the valve leaflets.
  • the expandable valve frame 50 and the valve leaflets 20 may be positioned and attached at a semilunar position of the heart by any appropriate technique.
  • the expandable valve frame 50 may be surgically implanted at a semilunar position of the heart.
  • valve leaflets 20 may be implanted
  • valve leaflets 20 may be implanted in a subsequent procedure to implantation of the expandable frame. Shown in FIGS. 2B and 2C, valve leaflets 20 of valve 11 are mounted to a stent 24. That is, portions of valve leaflets 20 are secured to a stent 24 for providing support to the valve.
  • a balloon 4 is appropriately placed into a semilunar region through positioning of the balloon using a catheter 2.
  • the valve 11 is inflated with a balloon 4.
  • Inflation of the balloon 4 depicted in FIG. 2C is shown by dashed arrows.
  • inflation of a balloon 4 applies pressure to the stent 24 and the valve 11 such that the valve 11 is pressed upon against the annular lumen of the vessel 12 at the semilunar position.
  • the diameter of both the expandable valve frame 50 and the vessel lumen may increase.
  • the expandable valve frame 50 to increase in diameter upon first implantation at a semilunar position of the heart, it is not a required aspect for suitable valve function.
  • the diameter of the vessel lumen at a semilunar position although the vessel may expand upon implantation of the expandable valve frame and the valve, it is not a requirement for appropriate valve function to result. Indeed, a slight degree of expansion and/or stretching of the vessel may occur when a balloon is properly inflated.
  • a vessel, as described herein is not limited to a blood vessel, but can include any suitable bodily conduit, such as a portion of connective tissue in the gastrointestinal system, or other suitable fluid passageways within the body.
  • the expandable valve frame 50 may be attached to the annular tissue.
  • the expandable valve frame 50 may be sutured to the surrounding tissue annulus at the point of implantation.
  • multiple sutures may be applied along the expandable valve frame 50, forming an attachment fit along the annular lumen so that the valve leaflets may function appropriately.
  • Methods of attachment may assist in reducing the risk of perivalvular leakage through a tight and closely conforming fit between the valve and the annulus.
  • the valve may be implanted in a manner similar to the Hancock Valve developed by Medtronic. It can be appreciated that stent- free valves may also be positioned at the proper site for cooperation with the expandable valve frame 50 as stent mounting is an optional embodiment.
  • valve leaflets 20 and an expandable valve frame 50 may be placed and attached at a semilunar position through a surgical technique without use for an added supporting structure.
  • the implanted valve may deteriorate to a point of malfunction
  • the implanted valve e.g., through disease, damage, and/or age. That is, upon malfunction, the implanted valve is unable to properly control flow unidirectionally away from the ventricle through the semilunar position or may become obstructed due to tissue ingrowth. In some cases, portions of the implanted valve are resorbed over time and through exposure to bodily fluids (e.g., blood). In other cases, portions of the implanted valve are left open or possibly torn.
  • bodily fluids e.g., blood
  • Inability for the implanted valve to properly function may include leakage, obstruction at the level of the valve frame, or through portions of the valve.
  • FIGS. 3A-3C depict an illustrative embodiment of an additional valve assembly 21 that is implanted at the location of the expandable valve frame 50. However, in FIGS. 3A-3C, the additional valve assembly 21 is used to restore function to the previously implanted valve 11.
  • FIG. 3A shows the previously implanted valve 11 in a deteriorated state, yet maintaining expandable valve frame 50.
  • Vessel 12 includes lumen debris 14 that may give rise to obstruction of the vessel.
  • Such debris 14 that may lead to at least partial occlusion of the vessel may include any material that is commonly associated with blood vessel or valve constriction, for example, biological debris (e.g., tissue), portions of the previously implanted valve, plaque, and/or combinations thereof.
  • FIG. 3A also depicts valve 11 having deteriorated portions 15 (e.g., holes, tears), depicted by dashed regions within valve leaflets 20, that further degrade function of the valve 11.
  • Additional valve assembly 21 includes valve leaflets, a catheter 2 for positioning of the assembly, and balloon 4 for assisting in the subsequent implantation.
  • FIG. 3B depicts a schematic of the additional valve assembly 21 being placed within the same annular region as the previously implanted valve the expandable valve frame 50.
  • the expandable valve frame 50 is provided as a docking station for the additional valve assembly 21.
  • the additional valve assembly 21 may be attached to the expandable valve frame 50 by any suitable method, for example, through an interlocking attachment mechanism or suturing.
  • the additional valve assembly 21 is pushed up against the inner wall of the vessel 12 in a manner that the valve assembly remains stably situated.
  • the additional valve assembly 21 is appropriately positioned as a stent-mounted valve (stent not shown in the figure).
  • a catheter 2 is depicted for positioning the additional valve assembly 21 in a similar location to that of the previously implanted valve, other positioning mechanisms may be used.
  • a balloon 4 may be used for providing an outward force on the additional valve assembly 21 and further anchoring the additional valve assembly 21 to the expandable valve frame 50.
  • the diameter of the expandable valve frame 50 increases upon inflation of the balloon 4 (indicated by dashed arrows).
  • an outward force may be applied to the expandable valve frame, increasing the diameter of the valve frame.
  • an inflatable balloon may provide the outward force to the expandable valve frame.
  • the additional valve assembly may also be implanted in the lumen where the prior valve was implanted such that the additional valve assembly restores the function of the previously implanted valve assembly.
  • the additional valve assembly may serve to support and/or hold open the previously implanted valve (e.g., valve leaflets).
  • the additional valve assembly may replace portions or the entirety of the prior valve.
  • multiple transcatheter valves may be implanted at a semilunar position of the heart as the additional valve assembly may include a second valve, third valve, or any subsequent valve.
  • the expandable valve frame can take a variety of forms.
  • the expandable valve frame may include one or more arcuate segments.
  • the expandable valve frame may have a single continuous, approximately circular segment.
  • the expandable valve frame may have three arcuate segments that span the same arc length over the same angle (e.g., 120 degrees). It should be understood that any number of arcuate segments may be included in the valve frame, each segment having an optionally different own arc length and angle.
  • the expandable valve frame is formed of a stretchable material that, when stretched beyond an elastic limit, may then exhibit a new larger diameter while maintaining rigidity.
  • the frame diameter is measured as the diameter between inner surfaces of a ring body.
  • the expandable valve frame may have a diameter of between about 5 mm and about 25 mm.
  • the expandable valve frame may have a diameter of between about 5 mm and about 15 mm; between about 5 mm and about 20 mm; between about 7 mm and about 25 mm; between about 10 mm and about 20 mm; between about 10 mm and about 25 mm; and/or between about 15 mm and about 25 mm.
  • the expandable valve frame may have a circumference of between about 20 mm and about 80 mm.
  • the expandable valve frame may have a circumference of between about 20 mm and about 50 mm; between about 20 mm and about 60 mm; between about 20 mm and about 70 mm; between about 22 mm and about 79 mm; between about 30 mm and about 60 mm; between about 30 mm and about 70 mm; between about 30 mm and about 80 mm; between about 40 mm and about 60 mm; between about 40 mm and about 70 mm; between about 40 mm and about 80 mm; between about 50 mm and about 60 mm; between about 50 mm and about 70 mm; between about 50 mm and about 80 mm; and/or between about 60 mm and about 80 mm.
  • the expandable valve frame may have a diameter of between about 10 mm and about 30 mm.
  • the expandable valve frame in a partially or fully expanded configuration, may have a diameter of between about 15 mm and about 30 mm; between about 20 mm and about 30 mm; between about 25 mm and about 30 mm; between about 10 mm and about 20 mm; and/or between about 10 mm and about 25 mm.
  • the expandable valve frame may have a circumference of between about 30 mm and about 95 mm.
  • the expandable valve frame may have a circumference of between about 30 mm and about 60 mm; between about 30 mm and about 70 mm; between about 30 mm and about 80 mm; between about 30 mm and about 95 mm; between about 31 mm and about 95 mm; between about 40 mm and about 60 mm; between about 40 mm and about 70 mm; between about 40 mm and about 80 mm; between about 40 mm and about 95 mm; between about 50 mm and about 60 mm; between about 50 mm and about 70 mm; between about 50 mm and about 80 mm; between about 50 mm and about 95 mm; between about 60 mm and about 70 mm; between about 60 mm and about 80 mm; between about 60 mm and about 95 mm; between about 70 mm and about 80 mm; between about 70 mm and about 95 mm; and/or between about 80 mm and about 95 mm.
  • the diameter of the expandable valve frame may be increased, for example, by placement of a stent-mounted valve within the lumen at a semilunar position and dilation of the stent outwardly (e.g., from inflation of a balloon). Radial strength and maintenance of the enlarged diameter may be provided, at least partially, by the expanded stent.
  • an expanded stent may not provide sufficient strength to protect against collapse in environments with high compressive, torsional, and/or cyclic stresses.
  • no stent is provided at a semilunar position where an expandable valve frame is implanted.
  • the diameter of the expandable valve frame does not decrease despite the ability for the ring diameter to be increased upon application of a sufficient outward force.
  • a oneway ratcheting mechanism may be used to increase the diameter of the expandable valve frame while substantially preventing the diameter of the expandable valve frame from decreasing.
  • a post-in-hole arrangement may be used as a one-way ratcheting mechanism for the expandable valve frame, which includes a central post that is connected to one of the segments of the body of the valve frame that may fit inside a corresponding hole in an adjacent segment.
  • the valve frame can expand at the joints by sliding of a post within a hole when an outward radial force is applied to the inner surface of the valve frame (e.g., inflation of an angioplasty balloon and/or expansion of a balloon-expandable stent or stent-mounted valve).
  • each segment may be connected to one another through such a post-in-hole arrangement.
  • the shape and dimensions of the post may vary, with cross- sectional profiles that are circular, asymmetric, square, rectangular, or any other suitable shape.
  • a post may vary in shape and dimension, for example, in order to optimize function, ratcheting, and/or axial, radial, or torsional strength.
  • dimensions of the system that are used for expansion may be pre-measured to better predict the appropriate ring diameter for successive implants.
  • a better prediction of the ring diameter for subsequent implants can lead to a better valve fit for the expandable valve frame, in turn, leading to longer term valve functionality. For example, if a post is straight or has a different radius of curvature than adjacent arcuate segments, each expansion may lead to distortion of the valve frame away from a perfect circle.
  • the expandable valve frame may be constructed such that the unexpanded ring is not quite circular (e.g., elliptical, crescent- shaped); the ring in a first expanded state is circular; and the ring in subsequently expanded states are supercircular (e.g., including straight edges from straight posts).
  • expandable valve frames having different mechanisms for expansion may also be contemplated.
  • a coiled arrangement may be incorporated between ends of segments of an expandable valve frame.
  • ends of segments may be distanced from one another upon application of a tensile force between coil ends. It should be understood that it is not a necessary requirement for the expandable valve frame to be made up of one or more segments. Indeed, as mentioned previously, the expandable valve frame may include a single segment with a diameter that can be increased as a result of an appropriate outward force placed on the ring.
  • a compacted structure may be included between segments of an expandable valve frame.
  • zigs or omega shaped elements that can be stretched out upon applying a sufficient tensile force may be included.
  • Struts may be incorporated in any appropriate manner, for example, along a coil or in between zigs or omega structures.
  • struts may include breaking points where upon a threshold tensile force applied, struts may break, allowing for segments of the expandable valve frame to be further distanced apart.
  • the expandable valve frame may include overlapping segments.
  • Overlapping segments may include arcuate segments with joints that are offset from one another at locations that provide the valve frame with increased overall radial and torsional stability.
  • the expandable valve frame may include one or more crescent- shaped segments.
  • Crescent- shaped segments for example, may be positioned adjacent to one another such that an outward force applied to the expandable valve frame allows for rotation and sliding of one or more crescent-shaped segments in a manner that increases the overall ring diameter.
  • FIGS. 4 and 5 illustrate an embodiment of valve 11 having an expandable valve frame 50 that includes a ring body 60 with three arcuate segments that form a continuous circular unit.
  • FIG. 4 illustrates the valve frame 50 in an unexpanded configuration.
  • the arcuate segments of the ring body 60 have the same radius of curvature R.
  • the arcuate segments depicted in this embodiment each span approximately 120 degrees. Alternatively, and as described above, the arcuate segments may span different and unequal arc lengths.
  • joints 70 In between arcuate segments of the ring body 60 are joints 70 that may function to expand valve frame 50 by distancing arcuate segments from one another.
  • valve leaflets 20 and struts 100 attached to the ring body 60 of the expandable valve frame 50 are also valve leaflets 20 and struts 100. Though not explicitly shown in FIG. 4, attachment of a valve leaflet 20 and the ring body 60 is located, for example, at the region depicted by the dashed circle.
  • the three struts 100 shown are each attached to at least one of the segments of the ring body 60. In FIG. 4, each strut 100 is attached to two neighboring segments of the ring body.
  • attachment of commissures of valve leaflets to a corresponding strut 100 is located, for example, at the region depicted by the dashed square.
  • Valve leaflets and associated commissures between valve leaflets may be attached to the ring body or a strut by any suitable method, such as through a sutured arrangement, an adhesive, a welded attachment, or other appropriate techniques.
  • leaflets are shown to be in a partially open position, but may operate to move to fully open and fully closed positions. It can be appreciated that upon implantation, a biocompatible material often surrounds the valve frame; however, the surrounding material is not shown for the purposes of clarity. For example, attachments of portions of valve leaflets, struts, and the ring body may occur through the material (not shown).
  • the valve that is attached to the expandable valve frame may or may not include struts that support the commissures.
  • struts may include a variety of appropriate designs.
  • struts may include a single post, a wire/segment of metal or other material that is arch-shaped, and/or another suitable design.
  • Struts may include various materials and with various degrees of stiffness and/or flexibility.
  • struts may generally be based on the design of existing stented and stentless bioprosthetic valve prostheses.
  • struts may include cut or formed metal lengths that are connected to the frame ring and rise in an axial dimension to support the commissures of the bioprosthetic valve.
  • Struts may take various forms. As shown in FIGS. 4 and 5, the three struts that support the three valve commissures may each connect to at least one of the segments of an expandable valve frame. Alternatively, as will be described below, the struts may span the expansion joints that serve as expandable connections and may additionally provide additional radial and torsional strength across the joints. In some embodiments, if a strut includes two or more segments, expansion of the joint and the width of the strut base may not shorten the strut but allow widening of the apex of the strut.
  • expansion of the expandable valve frame may alter the geometry of the valve leaflets and commissures, but may still allow adequate coaptation, such that the expanded valve will remain competent and functional without concentric implant of a transcatheter valve.
  • FIG. 5 depicts the valve 11 with the expandable valve frame 50 in a partially expanded configuration. Arcuate segments of ring body 60 are distanced from one another at joints 70. Similarly to in FIG. 4, one region of attachment of a valve leaflet 20 and the ring body 60 is located at the region depicted by the dashed circle. In addition, attachment of a valve leaflet 20 to a neighboring strut 100 is located at the region depicted by the dashed square. In FIG. 5, although the diameter of the expandable valve frame 50 is increased, the valve leaflets still remain attached to the ring body of the expandable valve frame in a manner that maintains overall functionality of the valve.
  • FIGS. 6A and 6B depict an illustrative embodiment of a strut 100 that spans a joint 70 between adjacent segments of a ring body 60, similarly to that shown in FIGS. 4 and 5.
  • the two adjacent segments of the ring body 60 with the strut 100 spanning the joint 70 are shown before expansion, in FIG. 6A, and after (or during) expansion, in FIG. 6B.
  • the strut 100 may widen and shorten with expansion of the joint 70.
  • struts that span joints may provide additional radial and torsional strength across the joints.
  • struts that span the joints will have two base attachment points, one attachment point for each of the adjacent ring segments. Upon expansion of the ring, these adjacent segments separate and the height of the strut shortens. For example, if a strut is composed of a single strand of wire, then the height of the strut will shorten as adjacent segments are distanced from each other.
  • FIG. 7 depicts the valve 11 with the expandable valve frame 50 in a partially expanded configuration.
  • Struts 100 are located at a central region of segments of the ring body 60. Arcuate segments of ring body 60 are distanced from one another at joints 70.
  • Valve leaflets and segments of the ring body may be appropriately attached by any suitable method. In some embodiments, when a valve leaflet is attached at a joint region of an expandable valve frame, the valve leaflet may be attached at multiple points to accommodate expansion of the joint. Additionally, commissures of valve leaflets and struts may also be appropriately attached by any suitable method, similarly to that described with respect to FIGS. 4 and 5. When the diameter of the expandable valve frame 50 is increased, the valve leaflets may still remain attached to the ring body of the expandable valve frame in a manner that maintains overall functionality of the valve.
  • FIGS. 8 A and 8B depict an illustrative embodiment of a strut 100 that is located at a central region of segments of the ring body 60, similarly to that shown in FIG. 7.
  • the struts, not spanning the joint 70, are illustrated before expansion, in FIG. 8A, and after (or during) expansion, in FIG. 8B.
  • each strut is only attached to a single segment of the ring body.
  • struts do not deform in the manner depicted above for struts that span joints.
  • FIG. 9 depicts an embodiment of a one-way ratcheting mechanism that includes a post-in-hole arrangement that helps to maintain the valve frame in the expanded diameter (i.e., preventing the ring diameter from decreasing) while allowing for subsequent re- expansions to larger ring diameters.
  • the joint 70 includes toothed regions 72 that are physically located in between segments of the ring body 60.
  • Joint 70 also includes a ratchet mechanism 74 at a hole 76.
  • the ratchet mechanism 74 functions to engage with toothed regions 72 such that segments of the ring body 60 are unable to come closer to one another, but can only be further distanced apart.
  • the regions 72 will remain in between segments outside of ring body 60.
  • the ratcheting mechanism 74 allows for circumferential and radial rigidity to be maintained, and also reduces the risk of fracture for valves (e.g., stent-mounted) that are deployed within the expandable valve frame 50.
  • the diameter of the valve frame 50 may be controlled by increasing the force required to expand to each successive ratchet position.
  • FIG. 10 depicts another illustrative embodiment of a one-way ratcheting mechanism that includes a toothed post-in-hole arrangement for maintaining the valve frame in an expanded diameter while allowing for subsequent re-expansions to larger ring diameters.
  • the joint 70 is located in between segments of a ring body 60 where a toothed region 72 of the joint is engaged with a ratchet mechanism 74 at a hole 76.
  • the ratchet mechanism 74 is in engagement with toothed regions 72 such that segments of the ring body 60 are unable to come closer to one another, but can only be further distanced apart.
  • the ratcheting mechanism 74 allows for circumferential and radial rigidity to be maintained, and also reduces the risk of fracture for valves (e.g., stent-mounted) that are deployed within the expandable valve frame 50.
  • FIG. 11 shows an embodiment of a toothed region 72 that includes teeth of graduated tooth size where expansion of the valve frame requires successively greater force for each increasing diameter.
  • toothed region 72d is larger than toothed region 72c, which is larger than toothed region 72b, which is larger than toothed region 72a.
  • toothed regions having graduated tooth sizes may include any suitable number of toothed regions having any suitable shape and/or dimensions.
  • the ratcheting mechanism may provide not only for an increased compressive stability, but may also provide for an increased torsional stability.
  • toothed regions may be shaped so that the expandable valve frame is prevented from collapsing under torsional stresses associated with twisting or shearing forces that may arise during or after implantation at a semilunar valve position.
  • the expandable valve frame may exhibit stability in torsion through generally stiff materials such as metal or rigid polymers, for example.
  • the expandable valve frame may exhibit stability in torsion through a layered arrangement, discussed further below.
  • an expandable valve frame in another illustrative embodiment shown in FIGS. 12, includes a body 60 and a joint 80 having a post 81 with a circular cross-section.
  • FIG. 12 shows a ball 82 that slides out of a hole 86 upon application of sufficient outward force on the valve frame. As illustrated, an interference fit exists between the ball 82 and the hole 86 such that a threshold force is required to pull the ball 82 out of the hole 86, leading to expansion of the valve frame.
  • FIG. 13 depicts another illustrative embodiment of an expandable valve frame including a body 60 and a joint 80 having a post 81 with a rectangular cross- section.
  • the joint 80 includes a ball 82 that slides out of a hole 86 upon application of sufficient outward force on the valve frame. An interference fit may exist between the ball 82 and the hole 86 such that a threshold force is required to pull the ball 82 out of the hole 86, leading to expansion of the valve frame.
  • a post with a rectangular cross-section may provide for added torsional stability of the expandable valve frame.
  • a post with a rectangular cross-section may have a greater height (axial dimension) h than a width (radial dimension) w. It can be appreciated that any appropriate type of joint mechanism and number of joints may be constructed in the expandable valve frame.
  • arcuate segments of the expandable valve frame may have joints other than the post-in-hole arrangement, as described above.
  • FIGS. 14-18 show other illustrative embodiments of expandable valve frames.
  • FIG. 14 depicts a partial view of an expandable valve frame 50 having a body 60 and a joint 90.
  • FIGS. 15-18 show various embodiments of joints that provide expandable mechanisms for the valve frame.
  • joints may include thick (or thin) gauged wire, metal, a relatively rigid material that stretches and sets under a threshold tensile force, and/or combinations thereof. Joints made of metal may, for example, be laser cut.
  • a joint 90 may include coils 92 that stretch out upon application of a tensile force.
  • the tensile force may originate, for example, from the body 60 transmitted from an outward force applied radially to the inner surface of the valve frame.
  • a joint may include zigs, coils, and/or omega structure(s) that may stretch out in a similar fashion to that of coiled structures.
  • joint 90 may include zigs 94 that are reinforced by supports 96 for holding the diameter of the expandable valve frame.
  • a tensile force may arise in the ring body when an outward force is applied to the valve frame.
  • one or more supports 96 When stretched to a particular tensile threshold, one or more supports 96 will break, and the zig 94 stretches such that the valve frame expands to a new diameter that is larger than the previous diameter.
  • the tensile threshold for breakage of the one or more supports for the valve frame to expand to a larger diameter ranges between about 12 atm and about 30 atm of balloon inflation pressure. It can be appreciated that the valve frame may be expanded multiple times by incorporating various configurations, for example, a nested zig/support structure and/or supports with different breaking points.
  • a joint 90 may include longer zigs 94 that are supported by shorter zigs 98 that, similar to supports 96 in FIG. 16, are designed to break under a particular threshold.
  • shorter zigs 98 may provide for varying elongation potential between ring body segments. For example, upon application of a tensile force, longer zigs 94 may only slightly stretch out where shorter zigs 98 may completely stretch out to the point of fracture.
  • the diameter of the expandable valve frame may slightly increase to a particular threshold (shorter zigs are stretched out) and then once the shorter zigs 98 break, the diameter of the expandable valve frame may further increase based on the length of the longer zigs 94.
  • a joint 90 may include longer zigs 94 that are supported by shorter zigs 99 or omegas that are located in orthogonal planes (e.g., zigs 94 are orthogonally positioned relative to zigs 99).
  • zigs 94 are orthogonally positioned relative to zigs 99.
  • FIG. 13 functions similarly to the embodiment depicted in FIG. 17 in that shorter zigs 99 may be stretched to a particular threshold limit before breaking. Upon breakage of shorter zigs 99, the diameter of the expandable valve frame is increased as portions of the ring body 60 are distanced further apart from one another.
  • FIGS. 19A and 19B illustrate an embodiment of valve 11 with an expandable valve frame 50 having overlapping segments 62, 64, and 66 in unexpanded and partially expanded configurations.
  • the expandable valve frame 50 is shown to be attached to valve leaflets 20 and struts 100, as described previously.
  • concentric rings may include arcuate segments, which, in some cases, may be thinner than in previous embodiments.
  • Segments 62, 64, and 68 form concentric rings having offsetting joints.
  • joints 102, 104, and 106 are offset from one another.
  • the offset between concentric rings may be even (e.g., 40 degrees offset). It can be appreciated that the offset between joints may be of any appropriate dimension and is not required to be evenly spaced.
  • segments within each concentric ring may or may not include a mechanism integrated into the ring for maintaining radial strength and/or diameter after expansion, such as a ratcheting system.
  • a concentric or layered arrangement may allow for added resistance to compressive loads and/or torsion.
  • a concentric or layered arrangement may include different materials for each layer designed according to varying loads experienced at different locations of the expandable valve frame. It can be appreciated that a layered arrangement is not required to be concentric, for example, different layers of the expandable valve frame may be side by side with the same diameter.
  • struts 100 are attached to only one of the concentric ring layers, as shown in FIG. 19A.
  • FIG. 19B depicts a closer illustration of the expandable valve frame 50 in a partially expanded configuration. As described above, as the diameter of the expandable valve frame 50 is increased, valve leaflets may remain attached to the ring body in a manner that maintains overall functionality of the valve.
  • the expandable valve frame may include overlapping crescent- shaped segments.
  • FIG. 20 depicts an expandable valve frame 50 with a body 60 having only four overlapping crescent- shaped segments, with the overlapping denoted by the dashed lines 110.
  • fewer or more crescent- shaped segments 110 may be fit together to form an expandable valve frame 50.
  • Overlapping crescent-shaped segments 110 may slide relative to one another, allowing for expansion of the ring diameter.
  • the expandable valve frame 50 may open as an aperture upon application of a sufficient outward radial force (e.g., during balloon dilation).
  • the apices of inner crescents of the overlapping crescent- shaped segments 110 may serve a ratcheting function, for example, with counteracting teeth on the inner surfaces of the outer ellipses.
  • an expandable valve frame 150 is formed of a strip of material 152 shaped into a cylinder and includes features that allow the cylinder to expand and to hold the cylinder at discrete diameter settings.
  • the expandable valve frame 150 incorporates a catch wheel ratcheting arrangement, as will be described below.
  • the strip is formed into a cylinder with overlapping ends 162 and 164.
  • the cylinder is self -biased toward a closed cylinder configuration having an unstressed diameter smaller than that desired. Upon expansion to overcome the spring bias, the cylinder opens to a larger desired diameter. Because the cylinder has a spring bias tending to cause the cylinder to seek a smaller diameter, the ratchet feature maintains the cylinder at the desired diameter.
  • the strip 152 may be formed of any suitable material such as plastic, metal (e.g., stainless steel), or composite and may have a width of between about 5 mm and 25 mm (e.g., between about 5 mm and about 15 mm), a length between about 40 mm and 100 mm, and a thickness that is approximately less than or equal to 0.1 inches (e.g., between 0.1 mm and about 0.4 mm).
  • the valve frame 150 may be expanded using any suitable technique. In one embodiment, the valve frame is expandable by balloon dilation, for example. The pressure applied by a balloon during expansion may be between about 2 atm and about 30 atm (in one embodiment, between about 2 atm and about 15 atm or, in another embodiment, between about 8 atm and about 30 atm).
  • the ratcheting arrangement forms a catch wheel type
  • protruding tabs may be formed on the strip as a separate component; however, in one embodiment, the protruding tabs are formed by stamping the strip 152 such that the protruding tab 171 extends partially out over a corresponding slot 174.
  • the strip may still include a slot over which the protruding tabs at least partially extend.
  • the protruding tabs 170, 171, 172 are shown protruding radially outward, some embodiments may have tabs that protrude radially inward.
  • Protruding tabs 170, 171, 172 may be separate components that are welded on, attached with adhesive, or attached with a mechanical linkage such as a rivet.
  • the leading edge of the strip 162 includes a leading edge tab 180, 182 such as shown in FIGS. 23A, 23B, 23C, 23D, 23G, 23H, 231, 23 J and 23Q.
  • the leading edge tab 180 may be formed with a slight bend so that it can penetrate through the slot 174.
  • Leading edge tab 180 may be a separate component that is welded on, attached with adhesive, or attached with a mechanical linkage such as a rivet. In this embodiment, the leading edge tab 180 penetrates through slot 174 and engages with the leading edge of slot 174 to hold diameter at an incremental position.
  • the valve frame may achieve a series of discrete diameter settings to create a suitable fit for specific valve sizes as shown in FIGS. 22A-22C.
  • One advantage to this embodiment is that the thin frame minimizes occlusion at the implantation site.
  • a planar strip of material with simple protrusions and cutouts is easy to manufacture, thus enabling ease of large-scale fabrication.
  • suitable expandable valve frames described herein may have any suitable diameter. In some embodiments, expandable valve frames have diameters between 15 mm and 24 mm.
  • an expandable valve frame may have an initial diameter of between about 10-20 mm (e.g., 16 mm diameter) prior to implantation of the valve frame, and after expansion within the body, the valve frame may have a diameter of between about 20-30 mm (e.g., 24 mm diameter).
  • protruding tab 172 When the cylinder is at a small diameter setting, such as in FIG. 22A, and there is an increased amount of overlap between the two overlapping ends of the strip 162 and 164, one protruding tab 172 catches the leading edge of the strip 162 while the preceding protruding tabs 170 and 171 (protruding tab 171 is not shown in FIG. 22A) sit under the leading edge end of the strip 163.
  • protruding tabs 170 and 171 under strip 163 will create a gap between the overlapping strip ends 162 and 164.
  • the strip 163 includes a plurality of evenly spaced slots located behind the leading edge 162. Though this plurality of evenly spaced slots is not shown, one of ordinary skill in the art will appreciate that, when the cylinder is at a small diameter, additional slots behind the leading edge 162 are necessary for the two overlapping ends 162 and 164 to lie flush to one another due to the presence of protruding tabs 170 and 172. In this embodiment, when the cylinder is at a small diameter setting, as shown in FIG.
  • one protruding tab 172 catches the leading edge of the strip while the other protruding tabs 170 and 171 penetrate through the corresponding slots.
  • protruding tabs 170, 171, and 172 release and the inner surface 166 of the leading edge 162 slips against the outer surface 168 of the opposite end of the strip 164 in the direction of increasing diameter.
  • the cylinder continues to expand until the leading edge 162 catches the next protruding tab 171, subsequently reengaging at a larger diameter, as shown in FIG. 22B.
  • the strip includes a plurality of cutouts 190 along the top and bottom edges of the cylinder, as shown in FIGS. 21, 22A-22C, and 23A-23R.
  • These cutouts 190 serve to vary the torsional stiffness and flexibility of the cylinder 150. For example, an increased number of cutouts would decrease the cross- sectional area of the cylinder and thus decrease its torsional stiffness and increase flexibility. Increased flexibility at certain sections of the cylinder 150 may be needed to maintain the circular nature of the cylinder.
  • these rectangular cutouts 190 are attachment sites for an encasing protective sheath 200, described in more detail later.
  • the expandable valve frame 150 may include, but is not limited to, any suitable combination of the arrangements and features.
  • One configuration of the strip as shown in FIGS. 23B, 23D, 23H, and 23J, includes an increased number of slots 174 and/or protruding tabs 171 (not shown) to permit finer diameter adjustment.
  • the leading edge of the strip includes a tapered tab 182 to guide the tab 182 more easily into each slot 174 and/or beneath a protruding tab 171.
  • an additional tab 184 located just behind the leading edge 162 of the strip, as shown in FIGS. 23B, 23D, 23H and 23J, is included.
  • This additional tab allows for a more secure hold.
  • This embodiment also allows for the engagement of multiple leading edge tabs 180, 184 with slots 174 to serve as a safety measure in the case of failure of one of the tabs.
  • two square tabs 186 are located on the leading edge, and a corresponding series of paired slots 187 are formed on the opposite end of the strip.
  • this double tab configuration may include tabs with tapered ends 188 such as in FIGS. 23F and 23L.
  • Tapered ends 188 may guide the tabs more easily into each pair of slots 187, as explained previously.
  • a recess 192, 195 may be provided in leading edge 162 to better engage with protruding tabs 170, 171, 172 and prevent axial slip. This recessed edge is shown in FIGS. 23M, 23N, 230, 23P, and 23R.
  • a series of protruding tabs 193 may be employed. In this arrangement, the cylinder 150 is held at a discrete diameter when the recess 192 on the leading edge 162 is tucked under one of the protruding tabs 193 located on the opposite end 168 of the strip.
  • the recess may have a square edge, 192 or a tapered edge, 195.
  • the tapered edge recess 195 may be angled so that it may allow the recess to slide more easily under a flap 193.
  • a series of protruding flaps 194 is formed on sides of the strip corresponding to the top and bottom edges of the cylinder, depicted by FIGS. 23G, 23H, 231, 23 J, 23K, 23L, 230, and 23P. These flaps may help to lock the frame in a circular shape and prevent the frame from twisting out of alignment.
  • these flaps or tabs may be bent over so as to essentially form a track through which the sides of the strip at the leading edge can follow.
  • two additional longitudinal fingers or leaflets 196 may be provided along the trailing side of the of the strip.
  • the leading edge 162 of the strip is tucked under the two leaflets 196.
  • the leaflets 196 may aid in guiding the leading edge of the strip during expansion, thereby preventing invagination of the cylindrical frame due to non-uniform dilation.
  • an expandable valve frame may employ differently shaped catch tabs, catch slots, alignment tabs, stabilization wings, suitable frame thicknesses, any other suitable arrangement, or combination thereof, which allows for the expandable valve frame to maintain discrete diameters upon appropriate expansion.
  • Table 1 provides short descriptions of various embodiments described above and depicted in FIGS. 23A-23R. It can be appreciated that the embodiments illustrated and discussed in FIGS. 23A-23R and Table 1 provide only exemplary descriptions of suitable expandable valve frames contemplated by the inventors, and therefore, the inventions described herein are not limited in this respect.
  • a non-cylindrical balloon may be employed to constrict the frame.
  • a dilated non-cylindrical balloon that presses outwardly on the frame along one line of action e.g. at 90 degrees and 270 degrees
  • the cylindrical frame is encased in a thin protective sheath 200 as shown in FIG. 24A to prevent in-growth of tissue into the ratcheting arrangement. In this manner, uninhibited dilation may be permitted.
  • the sheath fully encases the frame 150 between two walls 201 and 202 and, in some cases, the valve frame is permitted to slip relative to the sheath.
  • the seam 203 that joins the two walls 201 and 202 may be completely sealed with a stitch (such as a "baseball" stitch) that permits the sheath 200 to dilate.
  • the sheath 200 may be an elastic material, such as ePTFE (expanded Polytetrafuloroethylene), that can stretch as the frame 150 dilates.
  • the sheath 200 may be sewn to the cylindrical frame 150 at the rectangular cutouts 190 located along the top and bottom edge of the cylinder.
  • the sheath is shown semi-transparent for illustrative purposes to reveal the expandable valve frame 150 within the encasing sheath 200.
  • a cylindrical frame 150 enclosed by an outer biocompatible ePTFE sheath may also incorporate sewing cuffs on one or both sides of the device, for implantation within the body.
  • the sheath may include any other suitable biocompatible material besides ePTFE, for example, polymers such as polyester or polyimide.
  • the valve frame 30 supports a prosthetic valve 10.
  • a valve attachment frame 210 may be employed.
  • the attachment frame 210 is located about the expandable valve frame 150 and includes three evenly spaced valve post attachments 212 around the cylinder as shown in FIG. 25.
  • the expandable valve frame 150 is shown in phantom. Because the prosthetic valve 10 (not shown in FIG. 25) is attached to the expandable valve frame 150 via these valve post attachments 212 on the valve attachment frame 210, in one embodiment, the valve post attachments 212 are to remain substantially evenly spaced. The valve post attachments 212 loop around the top and bottom edges of the expandable valve frame 150.
  • Pliable diamond- shaped struts 214 connect the valve post attachments 212 to the wire-like external portion 216 of the attachment frame 210.
  • the diamond shape of the pliable struts 214 straighten, thereby permitting the wire attachment frame 210 to expand in the circumferential direction and allowing the three valve post attachments 212 to maintain consistent positions around the central axis.
  • valve when the valve is implanted at a "semilunar" position of the heart, the valve is said to be implanted at an aortic heart valve position or a pulmonary heart valve position.
  • aortic heart valve position As described herein, when the valve is implanted at a "semilunar" position of the heart, the valve is said to be implanted at an aortic heart valve position or a pulmonary heart valve position.
  • other locations are contemplated, as aspects are not limited in this regard.
  • an implantable device is contemplated to be expandable in one or more directions and providing an exterior conduit between two separate regions of tissue.
  • a valve which may or may not be expandable according to aspects described herein, may be appropriately disposed within the lumen of a bodily conduit, providing for fluid
  • the device includes a tube formed as a covered stent arrangement.
  • a stent mounted valve may provide a fluid conduit between a right ventricle and a main pulmonary artery that bypasses the natural anatomical passageway from the heart to the lungs.
  • Expandable cuffs may be positioned at opposite ends of the tube for suitable attachment (e.g., suturing) of ends of the device to the separate regions of tissue.
  • portions of the device are expandable (e.g., tube, valve, cuffs) so that the device may be surgically placed in smaller patients (e.g., children) with the ability for the device to be expanded at a later time.
  • the tube and/or valve may thus enable fluid flow between the ends of the device subsequent expansion.
  • the prosthesis may include any one of the previously described valve frames.
  • an expandable stent supporting the valve may be employed.
  • Expandable cuffs may be attached to ends of the tube by any suitable method, for example, and without limitation, through suturing, pressure/heat sealing and/or application of an adhesive.
  • a first tissue region e.g., an outer wall of a right ventricle having an opening to permit blood flow out of the chamber
  • a second tissue region e.g., an outer wall of the main pulmonary artery having an opening to permit blood flow into the pulmonary artery.
  • the device provides a passageway or conduit for fluid flow between the tissue regions, subject to opening and closing of the valve disposed within the tube.
  • the shape (e.g., curvature) of portions of the device are adjusted to circumvent certain anatomical features, such as for example, a sternum of a patient.
  • the device may be expanded, for example, to accommodate for patient growth in cases where the device was initially implanted into a child.
  • the device including the tube, the expandable cuffs and the valve, are expanded radially from an initial diameter to a larger diameter.
  • an initial diameter of the device may be about 10-20 mm (e.g., 15 mm) and a final diameter of the device may be about 21-31 mm (e.g., 26 mm).
  • the device may be expanded to any suitable diameter between the initial and final diameters (e.g., between about 15 mm and about 26 mm) depending on patient growth and/or other factors.
  • portions of the device may be lengthened from an initial length to a final length.
  • an initial length of the device may be about 1-10 mm (e.g., 5 mm) and a final length of the device may be about 10-20 mm (e.g., 15 mm).
  • the implantable device may be suitably dimensioned according to the size of the patient. Accordingly, a device may be longer and have a larger diameter for implantation in older children as compared to a device for implantation in infants, where a shorter and narrower device may be appropriate.
  • FIG. 26 illustrates a non-limiting example of an implantable device 300 that may be used to form a conduit between tissue regions in the body.
  • the device 300 includes an expandable valve 310 disposed within a stent 320 and expandable cuffs 330, 340 which are attached to the stent 320 at opposite ends.
  • the expandable cuffs 330, 340 may be formed of any suitable material, such as ePTFE (e.g., GORE- TEX ® ).
  • ePTFE e.g., GORE- TEX ®
  • Oppositely positioned expandable cuffs 330, 340 permit the device to be attached (e.g., anastomotically sutured) to respective tissue regions to create a fluid conduit between the tissue regions.
  • Other biocompatible materials, such as biological materials, may be employed in the cuffs.
  • the device 300 may also include a covering disposed over the stent 320 to prevent leakage of fluid from the device.
  • a covering may include any appropriate material, such as for example, ePTFE, biological materials, synthetic materials (e.g., polyester, polyimide, etc.) or other biocompatible materials, similar to the expandable cuffs.
  • a device covering and/or expandable cuffs include an anisotropic material having an orientation that provides for the device to be expanded in a desired manner (e.g., direction and degree of expansion).
  • a desired manner e.g., direction and degree of expansion
  • an expandable cuff and/or covering that includes an anisotropic material prone to expansion in one direction may be constructed so that the anisotropic material expands more readily, for example, in a radial direction as compared to a longitudinal direction, or vice versa.
  • the direction and degree of expansion of the device may be controlled through appropriate use and orientation of suitable materials.
  • the covering and/or expandable cuffs may include any biocompatible, generally compliant and thin material.
  • the covering and/or expandable cuffs may include engineered biomaterials, such as for example a collagen scaffold.
  • the device 300 may be expanded by any appropriate method.
  • an expandable balloon is used to enlarge portions of the device, such as the valve 310, the stent 320 and/or the expandable cuffs 330, 340. While the valve 310, the stent 320 and/or the expandable cuffs 330, 340 depicted in FIG. 26 can be suitably enlarged, it should be appreciated that not all portions of implantable devices described herein are required to be expandable. However, in certain embodiments, every portion of the implantable device is expandable.
  • Expandable cuffs 330, 340 are appropriately attached to the stent 320, for example, by application of an adhesive (e.g., glue), pressure/heat sealing and/or by suturing directly to the stent itself.
  • an adhesive e.g., glue
  • the expandable cuffs are attached on each end upon manufacture of the device, though the cuffs may be attached during implantation.
  • a covering that extends beyond the stent to provide cuff ends may be employed.
  • tissue regions upon implantation, the properties of tissue regions
  • the properties of the tissue at a right ventricle wall to which one cuff may be attached may differ substantially from the properties of the tissue at a wall of a pulmonary artery to which an opposing cuff may be attached.
  • an expandable cuff attached at an arterial outlet may be thicker than an expandable cuff attached at a venous outlet.
  • the expandable cuff having a larger thickness may be able to provide added support for accommodating increased fluid pressure at an arterial location in comparison to a venous location.
  • the device includes longer cuffs in certain anatomical regions for navigating the device around existing bodily structures, for example, a native outflow tract or a protruding atrium. It may be desirable for an implantable device to form a curved conduit from one tissue region to the other tissue region.
  • the device forms a conduit between the right ventricle and the pulmonary artery
  • the implantable device it may be advantageous for the implantable device to be adjustably bendable. That is, during implantation, it may be determined that the device should incorporate a substantial curvature to avoid the sternum, or alternatively, for other cases, the device might not require any curvature at all.
  • FIG. 27 depicts a curved mandrel 400 that an implantable device may be crimped around prior to implantation.
  • the mandrel 400 includes a central region 410, a first end portion 420 and a second end portion 430.
  • the central region 410 may have a diameter that is smaller than the first and second end portions 420, 430, to accommodate placement of the valve of the device during crimping.
  • a surgeon may have access to a plurality of curved mandrels having different curvatures, shapes and sizes from which to select. For example, the radius of curvature for one mandrel may be significantly larger than the radius of curvature for another mandrel.
  • a mandrel may include an irregularly or an elliptically- shaped arc.
  • a surgeon may inspect the anatomy of the patient and adjust the device (e.g., crimping about a suitably shaped mandrel) to incorporate the type of curvature that is most appropriate, upon implantation.
  • FIG. 28 is a schematic representation illustrating an arrangement 500 where portions of cells of a stent 510 are urged together by a restrictor 520. Upon dilation of the device during implantation, the presence of a restrictor 520 may induce curvature in the stent, hence, the device as a whole. As such, a surgeon may tailor the curvature of the device upon implantation of the device by deploying one or more restrictors at appropriate locations.
  • a restrictor applicator (not shown) is used to deploy and/or actuate restrictors between cells of a stent.
  • such an applicator may function similarly to a medical stapler where the user positions the applicator in an appropriate position and the restrictor is suitably placed into position.
  • the restrictor may be included on the device and the applicator may be used to actuate the restrictor imparting a desired curvature.
  • the implantable device may be suitably protected from external loading, such as, from contact with the sternum.
  • one or more ratcheting rings (not shown) and/or other suitable protection device(s) are positioned in spaced apart relation and placed external to the tube. Such an arrangement may support the device to maintain its structure upon experiencing contact with surrounding anatomical features.
  • a number of examples were designed and fabricated in accordance with various aspects described herein. In producing these examples, it was generally desirable to design a device that: has an adjustable diameter over a prescribed range of suitable diameters; can be expanded using suitable dilation devices (e.g., using catheter balloon dilation); may be implemented in conjunction with existing implantable valves (e.g., Melody Valve produced by Medtronic); is biocompatible; can be implanted within the body (i.e., human and animal); and exhibits a suitable degree of manufacturability.
  • suitable dilation devices e.g., using catheter balloon dilation
  • implantable valves e.g., Melody Valve produced by Medtronic
  • is biocompatible can be implanted within the body (i.e., human and animal); and exhibits a suitable degree of manufacturability.
  • FIGS. 24A and 24B illustrate two main subcomponents - an outer biocompatible barrier made of ePTFE, and an inner cylindrical valve frame that can be expanded and has a ratcheting structure.
  • the valve frame is encased inside of the outer biocompatible ePTFE barrier.
  • FIG. 29 illustrates a schematic of an expandable valve frame, having various dimensions, such as inner diameter A, width B and thickness C.
  • a number of design parameters were considered. Respective values for each of the design parameters are listed in Table 2, such as dimensions A, B, C, the number of ratchet settings, the maximum allowable strain of the wall of the bodily conduit per ratchet setting, and the expansion pressure of the expanding device (e.g., balloon).
  • suitable expandable valve frames in accordance with aspects of the invention may include parameters having values different than those listed below. Other parameters than those listed in Table 2 having appropriate ranges of values may also be considered and employed for suitable expandable valve frames.
  • Thickness (Dimension C in Fig. 29) Less than 0.4 mm
  • Expandable valve frames were formed through laser cutting (by Ameristar Laser Cutting, Inc.) from sheets of stainless steel 316L having thicknesses of 0.127 mm, 0.179 mm, 0.254 mm, and 0.381 mm.
  • the valve frames were expanded using a dilation catheter balloon from the smallest ratchet setting, having a diameter of 16 mm, to the next setting, having a diameter of 18 mm.
  • the valve frames were further expanded from a diameter of 18 mm to a diameter of 20 mm, and subsequently to a diameter of 22 mm.
  • the diameter of the dilation catheter balloon substantially matched the ratchet setting diameter of the valve frame.
  • an 18 mm dilation catheter balloon was used in expanding a valve frame from a 16 mm diameter to a 18 mm diameter.
  • valve frames of FIGS. 30A-30D, 31A-31D, 32A-32D, 33A-33C, and 34A-34B are generally of a similar design to those embodiments illustrated in FIGS. 23A, 23B, 23E, and 23M, respectively, yet have different values for width dimension B.
  • the valve frames of FIGS. 30A-30D have a width dimension B of 15 mm
  • the valve frames of FIGS. 31A-31D have a width dimension B of 10 mm
  • the width dimension B of the valve frames of FIGS. 32A-32D is 12 mm.
  • valve frames of FIGS. 33A-33C have a similar design as the embodiments depicted in FIGS. 23 A, 23B, and 23M, respectively, and have a width dimension B of 7 mm.
  • valve frames of FIGS. 34A and 34B are similar in design to the embodiments shown in FIGS. 23 A and 23B, respectively, and have a width dimension B of 5 mm.
  • valve frames of FIGS. 30A-34B have a plurality of cutouts 191 where cutouts along one edge of the valve frame are offset with respect to cutouts on an opposite edge of the valve frame. Similar to the cutouts 190 described previously, cutouts 191 may be used as attachment sites for the valve frame to be sutured to the protective sheath encasing and may also be suitable for varying the torsional stiffness and flexibility of the valve frame.
  • the offset alignment of the cutouts 191 may provide for a stronger attachment of the valve frame to the protective sheath encasing than that for the substantially aligned cutouts 190.
  • the examples shown in FIGS. 30A- 30C, 31A-31C, 32A-32C, 33A-33B, and 34A-34B include a slotted tab 169 which, in some cases, may allow for further flexibility of the valve frame to be engaged with a corresponding tab on the opposite side.
  • a slotted tab 183 may provide additional flexibility for the valve frame when placed into a functional arrangement prior to and/or after implantation.
  • valve frames were machined using wire-electrical discharge machining, so as to account for small clearances and tight tolerances.
  • Axially rigid ePTFE tubing having a diameter of 16 mm and a wall thickness of 0.127 mm was used as a sheath for each of the above valve frames.
  • each valve frame was inserted over the ePTFE tubing and the ePTFE tubing was then folded back over the valve frame.
  • the edges of the ePTFE tubing were then folded multiple times to form 2 mm wide cuffs.
  • the cuffs were then sutured with a 6-0 polypropylene baseball stitch, ensuring that enough suture length was included and allowing for full expansion of the respective valve frame.
  • Samples of ePTFE were obtained from Philips Scientific, Inc., Zeus Inc., and Applied Tubing Inc.
  • Embodiment Thickness Expansion from 16 Diameter Diameter
  • FIG. 30A 0.127
  • FIG. 30A 0.179
  • FIG. 30C 0.127
  • FIG. 30C 0.179
  • Crush test evaluations were performed on the expandable valve frames.
  • a DALSA vision system was used to record position and deformation of the valve frame by calculating the diameter on the crush axis.
  • a force sensor was used to record the force exerted on the crush axis.
  • Valve frames were crushed at a 16 mm diameter and at a 22 mm diameter, so as to provide upper and lower bounds for the load characteristics.
  • Fig. 35 shows the load plotted as a function of percent deformation for valve frames having a 16 mm diameter under crush testing.
  • Dotted curve 600 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.254 mm.
  • Solid curve 602 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.179 mm.
  • Dashed curve 604 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.127 mm.
  • Fig. 36 shows the load plotted as a function of percent deformation for valve frames tested having a 22 mm diameter subject to crush testing.
  • Dotted curve 700 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.254 mm.
  • Solid curve 702 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.179 mm.
  • Dashed curve 704 represents a range of load vs. percent deformation behavior of valve frames having a thickness of 0.127 mm.
  • Embodiments described may be for use as an improvement of the Melody
  • Transcatheter Pulmonary Valve manufactured by Medtronic, Inc.
  • aspects of the invention may be used in any suitable arrangement where a valve conduit is incorporated.
  • valve conduits described may be used to provide a fluid passageway between any appropriate regions, such as for example, between ends of a resected bodily vessel, cavities and/or channels within the body.
  • prosthesis described herein may be adapted for placement in other locations.
  • prosthesis described herein may include material that is radioopaque so that suitable imaging may occur.
  • Such alterations, modification, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description and drawings are by way of example only.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

Les procédés et appareils faisant l'objet de l'invention se rapportent à une valvule extensible qui peut être implantée dans le corps, par exemple à une position semi-lunaire du cœur. La valvule peut comprendre une structure de valvule extensible située autour d'un certain nombre de valves de valvule et peut être implantée chez de jeunes patients. Le diamètre de la structure de valvule extensible peut augmenter de manière appropriée afin de s'adapter à la croissance des patients, la valvule s'étirant en même temps que la structure de valvule. Selon certains modes de réalisation, une valvule extensible se trouve dans une endoprothèse vasculaire recouverte qui présente des manchons extensibles fixés aux extrémités opposées de l'endoprothèse vasculaire. Les manchons extensibles du dispositif peuvent être fixés chirurgicalement à des zones distinctes du tissu afin d'assurer une communication fluidique entre les zones du tissu. Selon un mode de réalisation, un manchon extensible fixé à une extrémité d'une endoprothèse vasculaire est suturé à une paroi extérieure d'un ventricule droit, et un manchon extensible fixé à l'extrémité opposée de l'endoprothèse vasculaire est suturé à une paroi extérieure de l'artère pulmonaire principale, ce qui crée un passage pour la circulation du fluide (c'est-à-dire du sang) entre le ventricule droit et l'artère pulmonaire principale, par l'intermédiaire de la valvule. Le dispositif implantable peut être extensible afin de s'adapter à la croissance des jeunes patients. Dans certains cas, la forme du dispositif peut être modifiée pour permettre le placement du conduit de valvule extensible à l'intérieur du corps.
PCT/US2011/046216 2010-08-02 2011-08-02 Valvule extensible et son procédé d'utilisation Ceased WO2012018779A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36977510P 2010-08-02 2010-08-02
US61/369,775 2010-08-02
US39072510P 2010-10-07 2010-10-07
US61/390,725 2010-10-07
US41220910P 2010-11-10 2010-11-10
US61/412,209 2010-11-10

Publications (2)

Publication Number Publication Date
WO2012018779A2 true WO2012018779A2 (fr) 2012-02-09
WO2012018779A3 WO2012018779A3 (fr) 2012-05-10

Family

ID=45560019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/046216 Ceased WO2012018779A2 (fr) 2010-08-02 2011-08-02 Valvule extensible et son procédé d'utilisation

Country Status (1)

Country Link
WO (1) WO2012018779A2 (fr)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140188221A1 (en) * 2012-12-31 2014-07-03 Edwards Lifesciences Corporation Surgical heart valves adapted for post-implant expansion
EP2853237A1 (fr) * 2013-09-25 2015-04-01 Universität Zürich Remplacement de valvule cardiaque biologique, en particulier pour des patients pédiatriques et procédé de fabrication
WO2015081175A1 (fr) 2013-11-26 2015-06-04 Children's Medical Center Corporation Valve d'endoprothèse extensible
JP2016508852A (ja) * 2013-03-08 2016-03-24 カーネギー メロン ユニバーシティ 拡張可能埋込型導管
CN105578993A (zh) * 2014-06-20 2016-05-11 爱德华兹生命科学公司 在植入后可识别的外科心脏瓣膜
WO2017004369A1 (fr) 2015-07-02 2017-01-05 Edwards Lifesciences Corporation Valvules cardiaques hybrides adaptées à dilatation post-implantation
WO2017044883A1 (fr) 2015-09-10 2017-03-16 Edwards Lifesciences Corporation Valvule cardiaque à expansion limitée
WO2018148714A1 (fr) * 2017-02-13 2018-08-16 Regents Of The University Minnesota Conduit de fluide présentant une expansibilité circonférentielle améliorée
US20180289475A1 (en) * 2012-12-31 2018-10-11 Edwards Lifesciences Corporation One-piece heart valve stents adapted for post-implant expansion
WO2018237020A1 (fr) 2017-06-21 2018-12-27 Edwards Lifesciences Corporation Valvules cardiaques à expansion limitée en forme de double fil
WO2019060533A1 (fr) * 2017-09-21 2019-03-28 The Cleveland Clinic Foundation Appareil de stent à dilatation progressive et procédé
EP3556323A1 (fr) * 2018-04-18 2019-10-23 St. Jude Medical, Cardiology Division, Inc. Valve cardiaque prothétique
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
WO2019241057A1 (fr) * 2018-06-11 2019-12-19 W. L. Gore & Associates, Inc. Mécanisme de réglage in vivo et systèmes et procédés associés
US10610357B2 (en) 2016-10-10 2020-04-07 Peca Labs, Inc. Transcatheter stent and valve assembly
US10624737B2 (en) 2011-07-29 2020-04-21 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
CN111818876A (zh) * 2017-11-16 2020-10-23 儿童医学中心公司 几何适应性心脏瓣膜置换装置
WO2020227359A1 (fr) * 2019-05-06 2020-11-12 W. L. Gore & Associates, Inc. Conduit à valve avec cadre extensible
US11000370B2 (en) 2016-03-02 2021-05-11 Peca Labs, Inc. Expandable implantable conduit
US11039919B2 (en) 2017-10-31 2021-06-22 W. L. Gore & Associates, Inc. Valved conduit
EP3838222A1 (fr) * 2019-12-18 2021-06-23 St. Jude Medical, Cardiology Division, Inc. Dispositifs et procédés d'expansion de valve chirurgicale
US11071626B2 (en) 2018-03-16 2021-07-27 W. L. Gore & Associates, Inc. Diametric expansion features for prosthetic valves
CN113573668A (zh) * 2019-02-04 2021-10-29 爱德华兹生命科学公司 强化再生心脏瓣膜
USD944398S1 (en) 2018-06-13 2022-02-22 Edwards Lifesciences Corporation Expanded heart valve stent
US11351058B2 (en) 2017-03-17 2022-06-07 W. L. Gore & Associates, Inc. Glaucoma treatment systems and methods
US20220183832A1 (en) * 2013-09-20 2022-06-16 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
CN115300177A (zh) * 2021-09-16 2022-11-08 武汉创而研之科技发展有限公司 一种新型带可降解单瓣叶的术中支架
US11559415B2 (en) 2019-03-26 2023-01-24 Edwards Lifesciences Corporation Radially self-expanding stents
USD977642S1 (en) 2018-10-29 2023-02-07 W. L. Gore & Associates, Inc. Pulmonary valve conduit
CN115813607A (zh) * 2021-11-15 2023-03-21 南京圣德医疗科技有限公司 一种自膨式生物瓣膜
US11617644B2 (en) 2014-10-13 2023-04-04 W. L. Gore & Associates, Inc. Prosthetic valved conduit
CN116196150A (zh) * 2022-02-15 2023-06-02 北京佰仁医疗科技股份有限公司 一种单向限位可扩张的人工生物心脏瓣膜
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
US11969342B2 (en) 2022-08-03 2024-04-30 The Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
RU2831895C1 (ru) * 2024-05-07 2024-12-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина" Министерства здравоохранения Российской Федерации Транскатетерный самораскрывающийся клапансодержащий протез для имплантации в позицию легочной артерии
US12239573B2 (en) 2018-08-29 2025-03-04 W. L. Gore & Associates, Inc. Drug therapy delivery systems and methods
US12527691B2 (en) 2021-11-05 2026-01-20 W. L. Gore & Associates, Inc. Fluid drainage devices, systems, and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258023A (en) * 1992-02-12 1993-11-02 Reger Medical Development, Inc. Prosthetic heart valve
US6530952B2 (en) * 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US7578843B2 (en) * 2002-07-16 2009-08-25 Medtronic, Inc. Heart valve prosthesis
US20060195186A1 (en) * 2005-02-28 2006-08-31 Drews Michael J Connectors for two piece heart valves and methods for implanting such heart valves

Cited By (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160296331A1 (en) * 2008-09-19 2016-10-13 Edwards Lifesciences Corporation Surgical heart valves adapted for post implant expansion
US10052200B2 (en) 2008-09-19 2018-08-21 Edwards Lifesciences Corporation Surgical heart valves adapted for post implant expansion
US11672651B2 (en) 2011-07-29 2023-06-13 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US10624737B2 (en) 2011-07-29 2020-04-21 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US20200093593A1 (en) * 2012-12-31 2020-03-26 Edwards Lifesciences Corporation Assembly of heart valves and intermediate adapter stent
CN104884002B (zh) * 2012-12-31 2017-04-05 爱德华兹生命科学公司 适于植入后扩张的外科心脏瓣膜
CN104884001A (zh) * 2012-12-31 2015-09-02 爱德华兹生命科学公司 植入后可扩展的外科心脏瓣膜构造
CN104884002A (zh) * 2012-12-31 2015-09-02 爱德华兹生命科学公司 适于植入后扩张的外科心脏瓣膜
US11576772B2 (en) 2012-12-31 2023-02-14 Edwards Lifesciences Corporation One-piece heart valve stents adapted for post-implant expansion
US20200155309A1 (en) * 2012-12-31 2020-05-21 Edwards Lifesciences Corporation One-piece heart valve stents adapted for post-implant expansion
US9364322B2 (en) * 2012-12-31 2016-06-14 Edwards Lifesciences Corporation Post-implant expandable surgical heart valve configurations
US9375310B2 (en) * 2012-12-31 2016-06-28 Edwards Lifesciences Corporation Surgical heart valves adapted for post-implant expansion
WO2014105760A1 (fr) 2012-12-31 2014-07-03 Edwards Lifesciences Corporation Configurations de valve cardiaque chirurgicale expansible post-implantation
US10485661B2 (en) 2012-12-31 2019-11-26 Edwards Lifesciences Corporation Surgical heart valves adapted for post-implant expansion
US20140188219A1 (en) * 2012-12-31 2014-07-03 Edwards Lifesciences Corporation Post-implant expandable surgical heart valve configurations
EP2938293A4 (fr) * 2012-12-31 2017-02-22 Edwards Lifesciences Corporation Configurations de valve cardiaque chirurgicale expansible post-implantation
US12226311B2 (en) 2012-12-31 2025-02-18 Edwards Lifesciences Corporation Heart valve stents adapted for post-implant expansion
US10543085B2 (en) 2012-12-31 2020-01-28 Edwards Lifesciences Corporation One-piece heart valve stents adapted for post-implant expansion
US20170281342A1 (en) * 2012-12-31 2017-10-05 Edwards Lifesciences Corporation Surgical heart valves adapted for post-implant expansion
US20140188221A1 (en) * 2012-12-31 2014-07-03 Edwards Lifesciences Corporation Surgical heart valves adapted for post-implant expansion
US11883282B2 (en) 2012-12-31 2024-01-30 Edwards Lifesciences Corporation Assembly of heart valves and intermediate adapter stent
US20180289475A1 (en) * 2012-12-31 2018-10-11 Edwards Lifesciences Corporation One-piece heart valve stents adapted for post-implant expansion
US10588746B2 (en) 2013-03-08 2020-03-17 Carnegie Mellon University Expandable implantable conduit
EP4094725A1 (fr) * 2013-03-08 2022-11-30 Carnegie Mellon University Conduit implantable extensible
JP2016508852A (ja) * 2013-03-08 2016-03-24 カーネギー メロン ユニバーシティ 拡張可能埋込型導管
US12144730B2 (en) * 2013-09-20 2024-11-19 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US20220183832A1 (en) * 2013-09-20 2022-06-16 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
EP2853237A1 (fr) * 2013-09-25 2015-04-01 Universität Zürich Remplacement de valvule cardiaque biologique, en particulier pour des patients pédiatriques et procédé de fabrication
US10292814B2 (en) 2013-09-25 2019-05-21 Universitaet Zuerich Biological heart valve replacement, particularly for pediatric patients, and manufacturing method
WO2015044193A1 (fr) * 2013-09-25 2015-04-02 Universität Zürich Prorektorat Mnw Prothèse de valvule cardiaque biologique, en particulier pour les patients pédiatriques, et procédé de fabrication
WO2015081175A1 (fr) 2013-11-26 2015-06-04 Children's Medical Center Corporation Valve d'endoprothèse extensible
US10478290B2 (en) 2013-11-26 2019-11-19 Children's Medical Center Corporation Expandable stent valve
US10130469B2 (en) 2014-06-20 2018-11-20 Edwards Lifesciences Corporation Expandable surgical heart valve indicators
US11154394B2 (en) 2014-06-20 2021-10-26 Edwards Lifesciences Corporation Methods of identifying and replacing implanted heart valves
JP2017213436A (ja) * 2014-06-20 2017-12-07 エドワーズ ライフサイエンシーズ コーポレイションＥｄｗａｒｄｓ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ 植込み後に識別可能な外科心臓弁
JP2016527063A (ja) * 2014-06-20 2016-09-08 エドワーズ ライフサイエンシーズ コーポレイションＥｄｗａｒｄｓ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ 植込み後に識別可能な外科心臓弁
CN105578993A (zh) * 2014-06-20 2016-05-11 爱德华兹生命科学公司 在植入后可识别的外科心脏瓣膜
US11617644B2 (en) 2014-10-13 2023-04-04 W. L. Gore & Associates, Inc. Prosthetic valved conduit
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
USD893031S1 (en) 2015-06-19 2020-08-11 Edwards Lifesciences Corporation Prosthetic heart valve
WO2017004369A1 (fr) 2015-07-02 2017-01-05 Edwards Lifesciences Corporation Valvules cardiaques hybrides adaptées à dilatation post-implantation
WO2017044883A1 (fr) 2015-09-10 2017-03-16 Edwards Lifesciences Corporation Valvule cardiaque à expansion limitée
US11000370B2 (en) 2016-03-02 2021-05-11 Peca Labs, Inc. Expandable implantable conduit
US12551339B2 (en) 2016-03-02 2026-02-17 Peca Labs, Inc. Expandable implantable conduit
US10631979B2 (en) 2016-10-10 2020-04-28 Peca Labs, Inc. Transcatheter stent and valve assembly
US10610357B2 (en) 2016-10-10 2020-04-07 Peca Labs, Inc. Transcatheter stent and valve assembly
WO2018148714A1 (fr) * 2017-02-13 2018-08-16 Regents Of The University Minnesota Conduit de fluide présentant une expansibilité circonférentielle améliorée
US12150897B2 (en) 2017-03-17 2024-11-26 W. L. Gore & Associates, Inc. Delivery aids for glaucoma shunts
US11523940B2 (en) 2017-03-17 2022-12-13 W. L. Gore & Associates, Inc. Delivery aids for glaucoma shunts
US11351058B2 (en) 2017-03-17 2022-06-07 W. L. Gore & Associates, Inc. Glaucoma treatment systems and methods
US11406533B2 (en) 2017-03-17 2022-08-09 W. L. Gore & Associates, Inc. Integrated aqueous shunt for glaucoma treatment
WO2018237020A1 (fr) 2017-06-21 2018-12-27 Edwards Lifesciences Corporation Valvules cardiaques à expansion limitée en forme de double fil
US20220008199A1 (en) * 2017-06-21 2022-01-13 Edwards Lifesciences Corporation Limited expansion heart valves
CN110831547A (zh) * 2017-06-21 2020-02-21 爱德华兹生命科学公司 双丝型件有限扩张心脏瓣膜
US11076954B2 (en) 2017-09-21 2021-08-03 The Cleveland Clinic Foundation Gradually-expandable stent apparatus and method
WO2019060533A1 (fr) * 2017-09-21 2019-03-28 The Cleveland Clinic Foundation Appareil de stent à dilatation progressive et procédé
US11039919B2 (en) 2017-10-31 2021-06-22 W. L. Gore & Associates, Inc. Valved conduit
US12186182B2 (en) 2017-10-31 2025-01-07 Edwards Lifesciences Corporation Valved conduit
CN111818876A (zh) * 2017-11-16 2020-10-23 儿童医学中心公司 几何适应性心脏瓣膜置换装置
CN111818876B (zh) * 2017-11-16 2024-02-09 儿童医学中心公司 几何适应性心脏瓣膜置换装置
US12004948B2 (en) 2017-11-16 2024-06-11 Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
US11071626B2 (en) 2018-03-16 2021-07-27 W. L. Gore & Associates, Inc. Diametric expansion features for prosthetic valves
US11903826B2 (en) 2018-03-16 2024-02-20 Edwards Lifesciences Corporation Diametric expansion features for prosthetic valves
EP3556323A1 (fr) * 2018-04-18 2019-10-23 St. Jude Medical, Cardiology Division, Inc. Valve cardiaque prothétique
US11234812B2 (en) 2018-04-18 2022-02-01 St. Jude Medical, Cardiology Division, Inc. Methods for surgical valve expansion
JP2021526916A (ja) * 2018-06-11 2021-10-11 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ 生体内調節機構、並びに関連システム及び方法
WO2019241057A1 (fr) * 2018-06-11 2019-12-19 W. L. Gore & Associates, Inc. Mécanisme de réglage in vivo et systèmes et procédés associés
AU2019284293B2 (en) * 2018-06-11 2022-08-11 W. L. Gore & Associates, Inc. In vivo adjustment mechanism and associated systems and methods
CN112261920A (zh) * 2018-06-11 2021-01-22 W.L.戈尔及同仁股份有限公司 体内调节机构以及相关系统和方法
CN112261920B (zh) * 2018-06-11 2024-05-24 W.L.戈尔及同仁股份有限公司 体内调节机构以及相关系统和方法
US11806261B2 (en) 2018-06-11 2023-11-07 W. L. Gore & Associates, Inc. In vivo adjustment mechanism and associated systems and methods
JP7100718B2 (ja) 2018-06-11 2022-07-13 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 生体内調節機構、並びに関連システム
USD979061S1 (en) 2018-06-13 2023-02-21 Edwards Lifesciences Corporation Expanded heart valve stent
USD944398S1 (en) 2018-06-13 2022-02-22 Edwards Lifesciences Corporation Expanded heart valve stent
US12239573B2 (en) 2018-08-29 2025-03-04 W. L. Gore & Associates, Inc. Drug therapy delivery systems and methods
USD977642S1 (en) 2018-10-29 2023-02-07 W. L. Gore & Associates, Inc. Pulmonary valve conduit
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
US12364603B2 (en) 2018-12-12 2025-07-22 W. L. Gore & Associates, Inc. Implantable component with socket
CN113573668B (zh) * 2019-02-04 2024-11-22 爱德华兹生命科学公司 强化再生心脏瓣膜
US20210361421A1 (en) * 2019-02-04 2021-11-25 Edwards Lifesciences Corporation Reinforced regenerative heart valves
CN113573668A (zh) * 2019-02-04 2021-10-29 爱德华兹生命科学公司 强化再生心脏瓣膜
US11559415B2 (en) 2019-03-26 2023-01-24 Edwards Lifesciences Corporation Radially self-expanding stents
WO2020227359A1 (fr) * 2019-05-06 2020-11-12 W. L. Gore & Associates, Inc. Conduit à valve avec cadre extensible
CN113811264A (zh) * 2019-05-06 2021-12-17 W.L.戈尔及同仁股份有限公司 带有可扩张框架的带瓣导管
CN113811264B (zh) * 2019-05-06 2025-04-22 爱德华兹生命科学公司 带有可扩张框架的带瓣导管
AU2020267416B2 (en) * 2019-05-06 2023-11-02 Edwards Lifesciences Corporation Valved conduit with expandable frame
EP3838222A1 (fr) * 2019-12-18 2021-06-23 St. Jude Medical, Cardiology Division, Inc. Dispositifs et procédés d'expansion de valve chirurgicale
US11382741B2 (en) 2019-12-18 2022-07-12 St. Jude Medical, Cardiology Division, Inc. Devices and methods for surgical valve expansion
CN115300177A (zh) * 2021-09-16 2022-11-08 武汉创而研之科技发展有限公司 一种新型带可降解单瓣叶的术中支架
CN115300177B (zh) * 2021-09-16 2024-06-11 武汉创而研之科技发展有限公司 一种新型带可降解单瓣叶的术中支架
US12527691B2 (en) 2021-11-05 2026-01-20 W. L. Gore & Associates, Inc. Fluid drainage devices, systems, and methods
CN115813607A (zh) * 2021-11-15 2023-03-21 南京圣德医疗科技有限公司 一种自膨式生物瓣膜
CN115813607B (zh) * 2021-11-15 2026-01-23 南京圣德医疗科技有限公司 一种自膨式生物瓣膜
AU2023221818B2 (en) * 2022-02-15 2025-01-16 Beijing Balance Medical Technology Co., Ltd. One-way limiting expandable artificial biological heart valve
CN116196150A (zh) * 2022-02-15 2023-06-02 北京佰仁医疗科技股份有限公司 一种单向限位可扩张的人工生物心脏瓣膜
US12303383B1 (en) 2022-02-15 2025-05-20 Beijing Balance Medical Technology Co., Ltd. One-way limiting expandable artificial biological heart valve
CN116196150B (zh) * 2022-02-15 2024-05-07 北京佰仁医疗科技股份有限公司 一种单向限位可扩张的人工生物心脏瓣膜
US11969342B2 (en) 2022-08-03 2024-04-30 The Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
RU2831895C1 (ru) * 2024-05-07 2024-12-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина" Министерства здравоохранения Российской Федерации Транскатетерный самораскрывающийся клапансодержащий протез для имплантации в позицию легочной артерии

Also Published As

Publication number Publication date
WO2012018779A3 (fr) 2012-05-10

Similar Documents

Publication Publication Date Title
WO2012018779A2 (fr) Valvule extensible et son procédé d'utilisation
JP7661449B2 (ja) 人工心臓弁デバイス
US12370042B2 (en) Devices, systems and methods for heart valve replacement
US12478473B2 (en) Valve prosthesis and method for delivery
US20250049565A1 (en) Prosthetic Heart Valves
CN113730033B (zh) 用于人工心脏瓣膜的密封构件
JP5379852B2 (ja) 潰れ可能かつ再膨張可能な人工心臓弁カフ設計および補完的技術出願
US10398546B2 (en) Mitral prosthesis and methods for implantation
JP7596149B2 (ja) 弁尖クランプを備えた機械的に拡張可能な心臓弁
ES3041498T3 (en) Reduced profile prosthetic heart valve
CN103491900B (zh) 用于二尖瓣修复和替换的系统
JP2013543397A (ja) 反内腔に位置する組織膜を有するフレームを伴う経皮的に送達可能な心臓または血管弁
WO2015081175A1 (fr) Valve d'endoprothèse extensible
US20220008233A1 (en) Self-growing heart valves
US20240315837A1 (en) Geometrically-accommodating heart valve replacement device
JP2025536735A (ja) 人工心臓弁用被覆材
WO2024211016A1 (fr) Déviation d'endoprothèse de prothèse valvulaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11815163

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11815163

Country of ref document: EP

Kind code of ref document: A2